Treme Bio
PrivateLast Round
Series B
Extension
Jan 27, 2026
Total Funding Raised
$219M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Treme Bio is a biotechnology company developing ProLymphNano, a patented drug delivery technology that focuses on the lymphatic system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Treme Bio Comparables
Compare Treme Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evoq Therapeutics | 74% | |
| Ropirio Therapeutics | 69% | |
| Elicio Therapeutics | 69% |
Treme Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 27, 2026 | ||||
| Series B | Nov 13, 2024 | ||||
| Series A Extension | Mar 8, 2022 | ||||
| Series A | Jun 22, 2021 |
Treme Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series B Extension |
| Agent Capital | Series B |
| Balyasny Asset Management L.P. | Series B Extension |
| SV Health Investors | Series B Extension, Series A, Series A Extension, Series B |
| Alexandria Venture Investments | Series B Extension, Series A, Series A Extension, Series B |
| Delos Capital Partners | Series B Extension, Series B |
| Polaris Partners | Series B Extension, Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2026
$50M raised from Alexandria Venture Investments and others.
- Nov 13, 2024
$84M round led by Delos Capital Partners.
Treme Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Treme Bio's valuation, stock price, and market status.
Is Treme Bio a public or private company?
Treme Bio is a private company.
What is the current stock price of Treme Bio?
Treme Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Treme Bio worth (valuation)?
Valuation information for Treme Bio is not publicly available.
Can I buy Treme Bio stock?
Treme Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Treme Bio's last funding round?
Funding round information for Treme Bio is not publicly available.
Who are the main investors in Treme Bio?
Investor information for Treme Bio is not publicly disclosed.
Will Treme Bio IPO soon?
No public IPO plans have been announced for Treme Bio.
How can I track Treme Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Treme Bio's secondary market activity and sign up for updates.